Fabiana Lascala1, Bruna Karoline da Silva Moraes1, Maria Carolina Santos Mendes1, Mariluce Barbosa de Carvalho1, Sandra Regina Branbilla1, Ademar Dantas da Cunha Júnior1,2,3, Luiz Roberto Lopes4, Nelson Adami Andreollo4, Lígia Traldi Macedo1, Carla M Prado5, José Barreto Campello Carvalheira6. 1. Division of Oncology, Department of anesthesiology, oncology and radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil. 2. Hematology and Oncology Clinics, Cancer Hospital of Cascavel, União Oeste de Estudos e Combate ao Câncer (UOPECCAN), Cascavel, PR, Brazil. 3. Department of Internal Medicine, State University of Western Paraná (UNIOESTE), Cascavel, PR, Brazil. 4. Division of Gastrointestinal Surgery, Department of Surgery, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil. 5. Human Nutrition Research Unit, Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada. 6. Division of Oncology, Department of anesthesiology, oncology and radiology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil. jbcc@unicamp.br.
Abstract
BACKGROUND/ OBJECTIVES: The association between systemic inflammation and myosteatosis upon diagnosis of gastric cancer (GC) and whether these factors could predict survival outcomes is not clear. Our aim was to explore the association between systemic inflammation and myosteatosis upon diagnosis of GC, specially whether the co-occurrence of these factors could predict survival outcomes. SUBJECTS/ METHODS: Computed tomography (CT) was performed at the level of the third lumbar vertebra for body composition analysis in 280 patients with GC. Myoesteatosis was defined as the lowest tertile of the muscle radiodensity distribution or based on clinical significance using optimal stratification analysis. Inflammatory indexes were measured, including the neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte and lymphocyte-to-monocyte ratios. RESULTS: Patients with low skeletal muscle (SM) radiodensity were more likely to be older than 65 years, have a higher body mass index and have diabetes. They also had higher intermuscular visceral and subcutaneous adipose tissue areas and indexes. The highest tertile of SM radiodensity was associated with better disease-free survival (DFS) (HR = 0.51, 95% CI [0.31, 0.84], ptrend = 0.020) and overall survival (OS) (HR = 0.49, 95% CI [0.29, 0.82], ptrend = 0.022). Patients with NLR > 2.3 and myosteatosis had the worst DFS and OS (HR = 2.77, 95% CI [1.54, 5.00], p = 0.001; HR = 3.31, 95% CI [1.79, 6.15], p < 0.001, respectively). CONCLUSION: Co-occurrence of myosteatosis and inflammation increased disease progression and death risk by almost three times. These regularly obtained biomarkers might improve prognostic risk prediction in resectable GC.
BACKGROUND/ OBJECTIVES: The association between systemic inflammation and myosteatosis upon diagnosis of gastric cancer (GC) and whether these factors could predict survival outcomes is not clear. Our aim was to explore the association between systemic inflammation and myosteatosis upon diagnosis of GC, specially whether the co-occurrence of these factors could predict survival outcomes. SUBJECTS/ METHODS: Computed tomography (CT) was performed at the level of the third lumbar vertebra for body composition analysis in 280 patients with GC. Myoesteatosis was defined as the lowest tertile of the muscle radiodensity distribution or based on clinical significance using optimal stratification analysis. Inflammatory indexes were measured, including the neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte and lymphocyte-to-monocyte ratios. RESULTS: Patients with low skeletal muscle (SM) radiodensity were more likely to be older than 65 years, have a higher body mass index and have diabetes. They also had higher intermuscular visceral and subcutaneous adipose tissue areas and indexes. The highest tertile of SM radiodensity was associated with better disease-free survival (DFS) (HR = 0.51, 95% CI [0.31, 0.84], ptrend = 0.020) and overall survival (OS) (HR = 0.49, 95% CI [0.29, 0.82], ptrend = 0.022). Patients with NLR > 2.3 and myosteatosis had the worst DFS and OS (HR = 2.77, 95% CI [1.54, 5.00], p = 0.001; HR = 3.31, 95% CI [1.79, 6.15], p < 0.001, respectively). CONCLUSION: Co-occurrence of myosteatosis and inflammation increased disease progression and death risk by almost three times. These regularly obtained biomarkers might improve prognostic risk prediction in resectable GC.
Authors: G F P Aleixo; S S Shachar; K A Nyrop; H B Muss; Luis Malpica; G R Williams Journal: Crit Rev Oncol Hematol Date: 2019-12-20 Impact factor: 6.312
Authors: Anna D Wagner; Florian Lordick; Heike I Grabsch; Masanori Terashima; Mitsumi Terada; Takaki Yoshikawa; Narikazu Boku; Kozo Kataoka; Elizabeth C Smyth; Murielle Mauer; Karin Haustermans; Markus H Moehler Journal: Eur J Cancer Date: 2019-11-20 Impact factor: 9.162
Authors: Amritpal S Bhullar; Ana Anoveros-Barrera; Abha Dunichand-Hoedl; Karen Martins; David Bigam; Rachel G Khadaroo; Todd McMullen; Oliver F Bathe; Charles T Putman; Michael T Clandinin; Vickie E Baracos; Vera C Mazurak Journal: J Cachexia Sarcopenia Muscle Date: 2020-01-27 Impact factor: 12.910
Authors: Rosaly Correa-de-Araujo; Odessa Addison; Iva Miljkovic; Bret H Goodpaster; Bryan C Bergman; Richard V Clark; Joanne W Elena; Karyn A Esser; Luigi Ferrucci; Michael O Harris-Love; Steve B Kritchevsky; Amanda Lorbergs; John A Shepherd; Gerald I Shulman; Clifford J Rosen Journal: Front Physiol Date: 2020-08-07 Impact factor: 4.566
Authors: Leandro Cardoso Barchi; Marcus Fernando Kodama Pertille Ramos; Osmar Kenji Yagi; Donato Roberto Mucerino; Claudio José Caldas Bresciani; Ulysses Ribeiro JÚnior; Nelson Adami Andreollo; Paulo Pimentel AssumpÇÃo; Antônio Carlos Weston; Ramiro Colleoni Neto; Bruno Zilberstein; Álvaro Antônio Bandeira Ferraz; Amir Zeide Charruf; André Roncon Dias; André Brandalise; André Maciel da Silva; Barlon Alves; Carlos Alberto Malheiros; Carlos Augusto Martinez Marins; Celso Vieira Leite; Daniel Szor; Durval R Wohnrath; Elias Jirjoss Ilias; Euclides Dias Martins Filho; Fabio Pinatel Lopasso; Felipe José Fernandez Coimbra; Fernando E Cruz Felippe; Flávio Daniel Saavedra Tomasisch; Flavio Roberto Takeda; Geraldo Ishak; Gustavo Andreazza Laporte; Herbeth José Toledo Silva; Ivan Cecconello; Joaquim José Gama Rodrigues; José Carlos Del Grande; Laércio Gomes Lourenço; Leonardo Milhomem da Motta; Leonardo Rocha Ferraz; Luis Fernando Moreira; Luis Roberto Lopes; Marcelo Garcia Toneto; Marcelo Mester; Marco Antônio Gonçalves Rodrigues; Marineide Prudêncio de Carvalho; Maurice Youssef Franciss; Nora Manoukian Forones; Oly Campos Corletta; Osvaldo Antonio Prado Castro; Osvaldo Malafaia; Paulo Kassab; Paulo Roberto Savassi-Rocha; Rodrigo Jose de Oliveira; Rubens Antonio Aissar Sallun; Rui Weschenfelder; Saint Clair Vieira de Oliveira; Thiago Boechat de Abreu; Tiago Biachi de Castria; Williams Barra; Wilson Luiz da Costa Júnior; Wilson Rodrigues de Freitas Júnior Journal: Arq Bras Cir Dig Date: 2020-12-18